Lv11
34 积分 2022-02-17 加入
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
4小时前
待确认
A second chance for telomerase reverse transcriptase in anticancer immunotherapy
14天前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks
2个月前
已完结
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
2个月前
已完结
Nociceptor-derived CGRP enhances dermal type I conventional dendritic cell function to drive autoreactive CD8+ T cell responses in vitiligo
2个月前
已完结
Structure of nucleosome-bound human BAF complex
4个月前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
4个月前
已完结
Contactin-4 suppresses antitumor T cell responses by engaging amyloid precursor protein
4个月前
已完结
皖公网安备34019202002308
